Category	Equity Scheme - Sectoral/ Thematic
NAV	92.64
Repurchase Price
Sale Price
Date	08-May-2020

HUL share price has zoomed 5% and is presently trading at Rs 2,098.

Meanwhile, the BSE FMCG Index is at 10,083 (up 2.0%).

Among the top Gainers in the BSE FMCG Index today are HUL (up 5.2%) and GSK CONSUMER (up 5.1%).

GODFREY PHILLIPS (down 0.3%) and GODREJ AGROVET LTD (down 1.0%) are among the top losers today.

Over the last one year, HUL has moved up from Rs 1,695 to Rs 2,098, registering a gain of Rs 402 (up 23.6%).

On the other hand, the BSE FMCG has moved down from 11,531 to 10,083, loss of 1,448 points (down 12.6%) during the last 12 months.

The top gainers among the BSE FMCG Index stocks during this same period were TATA CONSUMER PRODUCTS (up 74.6%), NESTLE (up 70.0%) and GSK CONSUMER (up 48.6%).

One Stock Crorepati: The Biggest Money-Making Opportunity Available Right Now

What About the Benchmark Indices?

The BSE Sensex is at 32,089 (up 0.8%).

The top gainers among the BSE Sensex stocks today are HUL (up 5.2%), RELIANCE IND. (up 4.0%) and NESTLE (up 3.9%). Other gainers include TECH MAHINDRA (up 3.6%) and SUN PHARMA (up 3.2%). The most traded stocks in the BSE Sensex are ICICI BANK and RELIANCE IND..

In the meantime, NSE Nifty is at 9,383 (up 0.7%). The top gainers in the NSE Nifty include HUL (up 5.1%), RELIANCE IND. (up 3.9%) and DR. REDDYS LAB (up 3.7%). Other gainers include TECH MAHINDRA (up 3.6%) and SUN PHARMA (up 3.3%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,277 to 32,089, registering a loss of 6,188 points (down 17.23%).

HUL Financial Update...

HUL net profit down at Rs 15 billion for the quarter ended March 2020, compared to a loss of Rs 16 billion a year ago. Net Sales declined 8.1% to Rs 90.1 billion during the period as against Rs 98.1 billion in January-March 2019.

For the year ended March 2019, HUL reported 19.6% increase in net profit to Rs 62.9 billion compared to net profit of Rs 52.6 billion during FY18.

Revenue of the company grew 8.5% to Rs 393 billion during FY19.

The current Price to earnings ratio of HUL, based on rolling 12 month earnings, stands at 67.3x.

This article (HUL Surges by 5%; BSE FMCG Index Up 2.0%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

Indian share markets ended their trading session on a positive note today.

Benchmark indices edged higher, tracking overnight gains in the US market and positive Asian stock markets.

Further, talks of an economic stimulus for small businesses battered by the coronavirus outbreak improved sentiment.

Reportedly, the government may unveil fiscal stimulus amounting to 0.3% of the country's gross domestic product, focusing on small and medium sized businesses, real estate firms and banks.

At the closing bell, the�BSE Sensex�stood higher by 199 points (up 0.6%) and the�NSE Nifty�closed higher by 52 points (up 0.6%).

SGX Nifty�was trading at 9,260, up by 64 points, at the time of writing.

The BSE Mid Cap�index ended up by 0.1%, while the�BSE Small Cap�index ended the day down by 0.5%.

On the sectoral front, gains were seen in the energy sector and FMCG sector, while power stocks witnessed selling pressure.

Asian stock markets�finished on a strong note as of the most recent closing prices.

The�Hang Seng�was up 1% and the Nikkei was trading higher by 2.6%. The Shanghai Composite was up 0.8%.

European markets were trading on a positive note. The DAX was trading up by 0.8%, while the CAC 40 was trading up by 0.7%.

The rupee was trading at 75.55 to the US$ at the time of writing.

Gold prices�are currently trading up by 0.2% at Rs 46,274.

Speaking of the current stock market scenario, Indian stock markets have seen a stunning recovery over the last 5 weeks.

From its all-time high levels of 42,274 touched on January 20 this year, the Sensex crashed 39% to a multi-year low at 25,639 on March 23. Later, the index made a rapid recovery till April 30 as it added 4,250 points.

Thereafter, in just two sessions of this month, Sensex lost 7%.

Excluding this week's 7% fall, of all the rebounds after a 35%-40% fall in the market, the current one has been the biggest by a distance.

This is evident from the chart below:

Sensex: From Bear to Bull in 30 Days

While the Sensex has rebounded sharply, there are still many stocks out there that are trading at attractive valuations.

Co-head of research at�Equitymaster, Rahul Shah, believes this is a good time to get into stocks, even if you missed the rally because the market is fairly valued.

History has shown that after years like the one we had just now, the next 3 years are good for the markets. In fact, these corrections are the rare times when you find businesses with solid fundamentals at reasonable valuations.

If you can�find good businesses�that can survive the current crisis, you will do well in the long run.

Moving on, market participants were tracking�Shree Cement share price,�TCI Express share price, and�SBI Cards and Payment Services share price�as these companies announced their March quarter results (Q4FY20) today.

You can read our recently released Q4FY20 results of other companies here:�Ambuja Cement,�IndusInd Bank,�Axis Bank,�Tech Mahindra,�Reliance Industries,�Marico,�Kansai Nerolac,�NIIT Technologies,�Persistent Systems,�SKF India.

In news from the banking sector, RBL Bank share price was in focus today.

The private lender on Thursday reported a 54% decline in its March quarter net profit to�Rs 1,143 million on the back of higher provisions.

The bank's total provisions trebled on a year-on-year (YoY) basis and stood at�Rs 6.1 billion in Q4FY20. It holds�Rs 1,079.5 million of provisions in excess of what RBI has mandated for covid-19 related moratorium.

The lender logged a 37% YoY growth in its operating profit at Rs 7.7 billion compared to Rs 5.6 billion a year ago.

The bank's total revenue jumped 33% YoY to Rs 15.2 billion from Rs 11.5 billion reported in Q4FY19.

RBL Bank's net interest margin (NIM) stood at 4.93% in the March quarter. Its net interest income (NII) grew 38% YoY to�Rs 10.2 billion in Q4FY20.

The bank's deposits fell 1% to�Rs 578.1 billion in Q4FY20. Current and savings account (Casa) deposits grew 17% and 2% sequentially to�Rs 171.1 billion in the March quarter.

The private lender's advances increased 7% to�Rs 580.2 billion.

For the financial year 2019-20, the bank's total income stood at Rs 55.4 billion, up 39% YoY from Rs 39.8 billion, while its operating profit jumped 42% YoY to Rs 27.5 billion.

To know more, you can read RBL Bank's Q4FY20 result analysis on our website.

Moving on to news from the pharma sector, shares of Dr Reddy's Laboratories rallied 8% today to hit a 52-week high of Rs 4,132, after the company received the Establishment Inspection Report (EIR) from US health regulator for its manufacturing plant at Srikakulam.

In a regulatory filing, the company said it has received EIR from the US Food and Drug Administration (USFDA), for the Active Pharmaceutical Ingredients (API) manufacturing plant at Srikakulam, Andhra Pradesh (CTO VI).

The site was issued warning letter in November 2015 after the inspection in 2014, and was under "Official Action Indicated" classification till now.

Dr Reddy's Laboratories share price ended the day up by 3.8%.

In other news, Laurus Labs share price witnessed selling pressure today. Stock of the company�slipped 10% today after more than 30 million equity shares of the pharmaceutical company changed hands via multiple block deals.

As much as 19.1 million shares were traded on BSE, while on the National Stock Exchange (NSE), about 15.3 million shares changed hands.

Last week, the company had reported its consolidated net profit at Rs 1.1 billion, which more than doubled from Rs 430 million reported in the year-ago quarter.

The company's board also recommended for the sub-division of equity shares of the company from existing face value of Rs 10 each to face value of Rs 2 each, subject to regulatory approvals.

Speaking of the pharma sector, in December 2019, co-head of Research at�Equitymaster, Tanushree Banerjee had predicted that pharma could be the sector to see a�big rebound in 2020.

And rightly so, most�pharma companies�have re-emerged as the safer bets for investors in the ongoing market turmoil. Last month, the Indian rupee touched a new record low of Rs 76.92 against the US dollar. Most�pharma companies�generate their revenues through exports. Hence, a depreciating rupee is a positive development for them.

As per Tanushree, in a�post Covid-19 world, healthcare expenditures globally will see a big rejig.

Tanushree has her eyes on an exciting tech stock. The company in question is developing its medical division. It's focusing on telemedicine, which Tanushree believes will be a huge growth driver in a post Corona world.

Looking at the potential upside in the stock, over a period of five to ten years, Tanushree believes investors could become a�One Stock Crorepati.

To know what's moving the Indian stock markets today, check out the most recent�share market updates here.

This article (Sensex Ends 199 Points Higher; Energy and FMCG Stocks Witness Buying) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

Company: Southern Labs
Experience: 6 to 15
location: Hyderabad / Secunderabad, Mumbai
Ref: 24826927
Summary: ASM/RSM/ZSM will be responsible for Appointment of SS and Distributors, overseeing sales operations,meeting targets and managing the sales team in the region.

Crown Equity Holdings Inc....

Full Article